- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05266482
Personalized Information Before and After Total Knee Arthroplasty: PAK-study (PAK)
April 26, 2022 updated by: Kliniek ViaSana
Personal Feedback on Patient-reported Outcomes to Fulfil or Exceed Preoperative Expectations of Primary Total Knee Arthroplasty Patients: PAK-study.
Despite positive results following total knee arthroplasty (TKA), some patients are dissatisfied after recovery.
Unfulfilled expectations is a key predictor of dissatisfaction.
The aim of this study is to investigate if more patients fulfil or exceed their preoperative expectations one year after TKA when personal feedback on their PROs is given.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
452
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: M.C.W.M. Peters, MSc
- Phone Number: 0031485476330
- Email: onderzoek@viasana.nl
Study Locations
-
-
-
Mill, Netherlands
- Recruiting
- Kliniek ViaSana
-
Contact:
- M. Peters
- Email: onderzoek@viasana.nl
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Planned for primary TKA in Kliniek ViaSana
- Signed informed consent
Exclusion Criteria:
- Aged under 18 years
- Do not possess an own email adress,
- Do not have a thorough command of the Dutch language,
- Previously received contra-lateral primary TKA and/or unicompartmental KA.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Next to the usual care, patients also get the opportunity to download and read a personal report.
|
In the intervention group, in addition to receiving the usual care, patients will receive personal reports on multiple time points.
These reports include feedback on their PROs including reference scores of patients who previously underwent total knee replacement surgery.
|
|
No Intervention: Control group
Patients will receive the usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' expectations
Time Frame: 12 months after surgery
|
The percentage (0%-100%) of patients who fulfil or exceed their preoperatively set expectations 12 months after TKA surgery.
Measured using HSS-KRES.
|
12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' expectations
Time Frame: 3 and 6 months after surgery
|
The percentage (0%-100%) of patients who fulfil or exceed their preoperatively set expectations 3 and 6 months after TKA surgery.
Measured using HSS-KRES.
|
3 and 6 months after surgery
|
|
Patients' satisfaction
Time Frame: 3, 6 and 12 months after surgery
|
Satisfaction score with the outcome of TKA surgery.
Measured using NRS satisfaction from 0 (dissatisfied) to 10 (satisfied).
|
3, 6 and 12 months after surgery
|
|
Pain relief
Time Frame: 3, 6 and 12 months after surgery
|
Measured on a scale from 1 (very much deteriorated) to 7 (very much improved)
|
3, 6 and 12 months after surgery
|
|
Functional improvement
Time Frame: 3, 6 and 12 months after surgery
|
Measured on a scale from 1 (very much deteriorated) to 7 (very much improved)
|
3, 6 and 12 months after surgery
|
|
Perceived recovery
Time Frame: 3, 6 and 12 months after surgery
|
Measured on a scale from 0 (worse than ever) to 6 (fully recovered)
|
3, 6 and 12 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: J.M. Brinkman, MD, PhD, Kliniek ViaSana
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 9, 2022
Primary Completion (Anticipated)
December 1, 2024
Study Completion (Anticipated)
December 1, 2024
Study Registration Dates
First Submitted
February 23, 2022
First Submitted That Met QC Criteria
February 23, 2022
First Posted (Actual)
March 4, 2022
Study Record Updates
Last Update Posted (Actual)
April 27, 2022
Last Update Submitted That Met QC Criteria
April 26, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- N21.077
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Knee Arthroplasty
-
Cedars-Sinai Medical CenterPacira Pharmaceuticals, IncEnrolling by invitationTotal Knee Arthroplasty | Total Knee Arthroplasty RecoveryUnited States
-
Limacorporate S.p.aRecruitingTotal Knee Arthroplasty | Revision Total Knee ArthroplastyUnited Kingdom, Portugal, Slovakia
-
Northern Orthopaedic Division, DenmarkCompletedTotal Knee Arthroplasty | Total Hip ArthroplastyDenmark
-
Copenhagen University Hospital, HvidovreUniversity of Southern Denmark; University Hospital Bispebjerg and FrederiksbergNot yet recruitingKnee Arthroplasty | Total Knee Arthroplasty | Unicompartmental Knee Arthroplasty
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
University of North Carolina, Chapel HillNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedKnee Arthroplasty, Total | Knee Replacement, TotalUnited States
-
The Affiliated Hospital Of Southwest Medical UniversityCompletedTotal Knee Arthroplasty | Total Hip Arthroplasty | ERASChina
-
Istanbul UniversityCompleted
-
Singapore General HospitalCompletedTotal Knee Arthroplasty | Total Knee ReplacementSingapore
Clinical Trials on Personal report
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)UnknownDiabetes Mellitus, Type 2Canada
-
Global Kinetics CorporationTerminatedParkinson DiseaseUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Memorial University of NewfoundlandCompletedUrinary Tract Infections | Asymptomatic BacteriuriaCanada
-
MYnd AnalyticsMount Sinai Hospital, New YorkSuspended
-
MYnd AnalyticsUniversity of Ottawa; Canadian Forces Health Services Centre OttawaUnknownDepression | Non-psychotic Diagnosis as Co-morbidityCanada
-
Shandong UniversityUnknown
-
Vanderbilt UniversityCompleted
-
University of Massachusetts, AmherstCompleted
-
Sunnybrook Health Sciences CentreCancer Care OntarioCompleted